Hemant Surgical Industries Ltd
₹ 108
-1.01%
21 May
2:21 p.m.
About
Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]
Key Points
- Market Cap ₹ 113 Cr.
- Current Price ₹ 108
- High / Low ₹ 225 / 88.2
- Stock P/E 12.4
- Book Value ₹ 55.6
- Dividend Yield 0.00 %
- ROCE 29.8 %
- ROE 25.0 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 54.0% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.9%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Earnings include an other income of Rs.4.08 Cr.
- Working capital days have increased from 30.6 days to 74.4 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Upcoming result date: 28 May 2025
Profit & Loss
Figures in Rs. Crores
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 51 | 56 | 56 | 60 | 101 | 109 | 106 | 107 | |
| 48 | 53 | 53 | 57 | 95 | 98 | 95 | 96 | |
| Operating Profit | 2 | 3 | 3 | 3 | 6 | 11 | 10 | 11 |
| OPM % | 5% | 5% | 5% | 5% | 6% | 10% | 10% | 10% |
| 0 | 0 | 0 | 1 | 2 | 2 | 4 | 4 | |
| Interest | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 |
| Depreciation | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 1 | 1 | 1 | 1 | 6 | 10 | 13 | 13 |
| Tax % | 10% | 8% | 41% | 9% | 25% | 24% | 23% | |
| 1 | 1 | 0 | 1 | 5 | 8 | 10 | 9 | |
| EPS in Rs | 50.76 | 61.02 | 27.00 | 73.43 | 248.92 | 9.95 | 9.39 | 8.68 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 21% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 54% |
| 3 Years: | 93% |
| TTM: | -2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 32% |
| Last Year: | 25% |
Balance Sheet
Figures in Rs. Crores
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 8 | 10 | 10 |
| Reserves | 5 | 6 | 5 | 8 | 11 | 16 | 44 | 48 |
| 9 | 11 | 14 | 14 | 10 | 7 | 7 | 14 | |
| 12 | 14 | 23 | 15 | 32 | 34 | 35 | 43 | |
| Total Liabilities | 28 | 33 | 44 | 40 | 54 | 65 | 97 | 116 |
| 7 | 8 | 10 | 11 | 12 | 13 | 18 | 33 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 1 | 0 | 1 | 0 | 5 | 0 |
| 21 | 25 | 33 | 29 | 42 | 51 | 74 | 83 | |
| Total Assets | 28 | 33 | 44 | 40 | 54 | 65 | 97 | 116 |
Cash Flows
Figures in Rs. Crores
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 2 | -4 | 12 | 6 | -8 | |
| 0 | 0 | -2 | -2 | -0 | -3 | -9 | |
| 0 | 0 | 2 | 5 | -8 | -1 | 21 | |
| Net Cash Flow | 0 | 0 | 2 | -2 | 4 | 3 | 5 |
Ratios
Figures in Rs. Crores
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 35 | 36 | 35 | 26 | 56 | 58 | 75 |
| Inventory Days | 64 | 73 | 125 | 113 | 57 | 67 | 99 |
| Days Payable | 102 | 97 | 143 | 89 | 92 | 110 | 116 |
| Cash Conversion Cycle | -3 | 12 | 17 | 51 | 21 | 15 | 58 |
| Working Capital Days | 12 | 23 | 14 | 66 | 2 | 16 | 74 |
| ROCE % | 15% | 12% | 14% | 32% | 45% | 30% |
Documents
Announcements
-
Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For Half And Financial Year Ended On March 31, 2025.
16 May - Board meeting on May 28 to approve audited results for half and full year ending March 31, 2025.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
28 Apr - Confirms Hemant Surgical is not a Large Corporate as per SEBI criteria for FY 2024-25.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - Certificate confirming shares in demat form for Q1 2025.
- Closure of Trading Window 27 Mar
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
13 Mar - Acquisition of Solar Opto-Medic completed, now a subsidiary.
Business Overview:[1][2]
HSIL is ISO 9001:2015, ISO 13485:2016 certified and CDSCO compliant company which deals in importing, manufacturing, and marketing medical disposable, surgical equipments and pharmaceutical products including
a) Supply of dialysis equipment, renal care, oxygen concentrators, air mattresses, ultrasound machines and digital thermometers, etc.
b) Design and manufacture of a range of nebulisers, which are
marketed under the company’s AERO brand
c) HSIL also refurbishes second-hand dialysis machines, manufactures
and supplies related accessories, dialysers and haemodialysis solutions